Genomics in Drug Discovery Webinar 3: Decoding Success using Functional Genomics in Drug Discovery

Webinar 3: Decoding Success using Functional Genomics in Drug Discovery

Thursday 21st of March 2024 at 3pm BST / 4pm CET/ 10am EST

This webinar will review how functional genomic tools can enable the systematic exploration of genetic elements for, and the rigorous validation of, novel and promising drug targets. It will demonstrate how the incorporation of functional genomic capabilities into conventional drug development pipelines is predicted to expedite the development of first-in-class therapeutics.

Talk 1: Application of CRISPR-cas9 for iPSC-Models in Drug Discovery - Matteo Martufi, Associate Director, GSK

Talk 2: Using Pooled CRISPR Screening to Drive Oncology Drug Discovery - David Walker, Group Leader Functional Genomics, Cancer Research Horizons

Talk 3: From Genes to Mechanism: Population-Level Proteogenomics - Ryan Dhindsa, Assistant Professor, PI, Baylor College of Medicine

Previous webinars available on-demand:

Webinar 1: Revolutionizing Genomics through AI in Drug Discovery

Thursday 7th of March 2024 at 3pm BST / 4pm CET/ 10am EST

Introducing the power of AI algorithms, this webinar will delve into how AI/ML is reshaping the landscape of drug discovery. The webinar will tackle the management and integration of big data to rapidly and accurately identify potential drug targets, intricate biological networks, and ultimately provide a holistic understanding of target interactions.

Talk 1: Integrated Genomics and Transcriptomics Based Approaches for Predicting Drug Response Biomarkers - Harpreet Saini, Senior Director, Bioinformatics, Astex Pharmaceuticals

Talk 2: Omics Data Management and Analytics - Felix Francis, Senior Manager, Data Management and Analytics, Takeda

Webinar 2: Tackling Genetic Diversity through Translational Models & Patient Stratification for Effective Target Discovery

Thursday 14th of March 2024 at 3pm BST / 4pm CET/ 10am EST

This webinar will uncover how incorporating diverse genetic backgrounds contributes to the development of targeted therapeutics. The webinar will shed light on amplifying genetic diversity in preclinical and translational studies through exploring in-vitro models for indication-relevant assays and patient stratification.

Talk 1: Developing & Defining Translatable in-vitro Models & Indication Relevant Assays - Emma Laing, Director, Computational Biology, GSK

Talk 2: Biomarker-Selected Patient Stratification Driving Precision Oncology - Dipti Thakkar, Vice President, Target Biology & Pharmacology, Hummingbird Bio

Talk 3: Pulse RNA Library Screens as a Method of Target Discovery in Myeloid Malignancies - Jamshid Khorashad, Honorary Senior Lecturer & Scientific Consultant, Imperial College London